We provide independent research and advice that helps companies communicate with investors. Find out what we do >
2018 – failed to meet expectations The Hardman & Co Healthcare Index (HHI) has been running since 2009. Its main function is to highlight the attractions of life sciences investments over the long term. 2018 was a difficult year; however, the index still outperformed its comparative London indices, falling 10.0% to 393.2, compared with -13.0& […]
Accounting scams are probably even more prevalent today than formerly. Steve Clapham investigates.
Revisiting the issue of stock liquidity and examining the initial effect of MiFID II.
Our deep sector knowledge and experience illuminates value for companies and brings clarity to investors.
We produce detailed and unbiased reviews into the latest tax enhanced products, for managers, advisers and investors.
Burford’s performance continues to reward long-term investors. Since engaging Hardman & Co, our shareholder base has widened, and liquidity has improved. We are pleased with these results and Hardman & Co’s help in getting us to where we are today
Elizabeth O'Connell, Chief Financial OfficerRead their story